235 related articles for article (PubMed ID: 6955593)
1. Taking university research into the marketplace.
Omenn GS
N Engl J Med; 1982 Sep; 307(11):694-700. PubMed ID: 6955593
[No Abstract] [Full Text] [Related]
2. Biomedical research enters the marketplace.
Culliton BJ
N Engl J Med; 1981 May; 304(20):1195-201. PubMed ID: 6938776
[No Abstract] [Full Text] [Related]
3. Managing innovation: university-industry partnerships and the licensing of the Harvard mouse.
Blaug S; Chien C; Shuster MJ
Nat Biotechnol; 2004 Jun; 22(6):761-4. PubMed ID: 15175696
[No Abstract] [Full Text] [Related]
4. Industry and academia in transition.
Kennedy D
Science; 2003 Nov; 302(5649):1293. PubMed ID: 14631000
[No Abstract] [Full Text] [Related]
5. Regulating scientific research: intellectual property rights and the norms of science.
Rai AK
Northwest Univ Law Rev; 1999; 94(1):77-152. PubMed ID: 12784815
[No Abstract] [Full Text] [Related]
6. Public-private partnerships in biomedical research: resolving conflicts arising under the Federal Technology Transfer Act of 1986.
Bulleit TN
J Law Health; 1989-1990; 4(1):1-20. PubMed ID: 11652568
[No Abstract] [Full Text] [Related]
7. Taking the profit out of biomedical research tools.
Flores MA
Nat Biotechnol; 1999 Aug; 17(8):819-20. PubMed ID: 10429252
[TBL] [Abstract][Full Text] [Related]
8. A policy for biomedical research. Report of an Ad Hoc Committee of the Council of Academic Societies of the Association of American Medical Colleges.
J Med Educ; 1971 Aug; 46(8):689-743. PubMed ID: 4997950
[No Abstract] [Full Text] [Related]
9. Biomedical research policy--a re-evaluation.
Ebert RH
N Engl J Med; 1973 Aug; 289(7):348-51. PubMed ID: 4718514
[No Abstract] [Full Text] [Related]
10. Keeper of the stem cells.
Lemonick MD
Time; 2001 Aug; 158(8):57. PubMed ID: 11534482
[No Abstract] [Full Text] [Related]
11. Razing the tollbooths. A call for restricting patents on basic biomedical research.
Stix G
Sci Am; 2003 Apr; 288(4):37. PubMed ID: 12661312
[No Abstract] [Full Text] [Related]
12. Biobusiness on campus: commercialization of university-developed biomedical technologies.
Dueker KS
Food Drug Law J; 1997; 52(4):453-509. PubMed ID: 10346675
[No Abstract] [Full Text] [Related]
13. How a corporate feud doomed human trials of promising therapy.
Richards B
Wall St J (East Ed); 1999 Aug; ():A1, A6. PubMed ID: 11647670
[No Abstract] [Full Text] [Related]
14. Policy directions for the National Heart, Lung, and Blood Institute: implications for academia and industry.
Lenfant C
Circulation; 1985 Aug; 72(2 Pt 2):I44-7. PubMed ID: 4006158
[No Abstract] [Full Text] [Related]
15. Drug prices: real problem, wrong solution.
Kennedy D
Science; 2001 Jun; 292(5523):1797. PubMed ID: 11397914
[No Abstract] [Full Text] [Related]
16. NCCAM awards grants to CAM institutions to enhance research education.
Kreitzer MJ; Sierpina VS
Explore (NY); 2008; 4(1):74-6. PubMed ID: 18194798
[No Abstract] [Full Text] [Related]
17. The government and the universities.
MacLeod CM
Trans Assoc Am Physicians; 1966; 79():99-106. PubMed ID: 5953759
[No Abstract] [Full Text] [Related]
18. Patents. NIH to limit scope of foreign patents.
Kaiser J
Science; 2002 Jun; 296(5577):2316. PubMed ID: 12089417
[No Abstract] [Full Text] [Related]
19. A national policy for biomedical and behavioral research: position of the Association of American Medical Colleges.
Berne R; Cooper T; Skinner D; Sanders C; Whybrow PC; Halvorson H; Dodge PR; Thier SO; Morgan TE; Dolan KS
Clin Res; 1979 Feb; 27(1):1-13. PubMed ID: 10241606
[No Abstract] [Full Text] [Related]
20. Research funding. Research downturn.
Science; 2008 Aug; 321(5893):1144. PubMed ID: 18755947
[No Abstract] [Full Text] [Related]
[Next] [New Search]
